Linical and Accelovance Merge Under New Linical Name


Applied Clinical Trials

Linical and Accelovance merged to create a global CRO with a significant footprint across North America, Europe and Asia-Pacific. Under this merger, they will be called Linical and have appointed a new CEO, Vita M. Lanoce.   Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.